• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Terazosin Teva
    / Teva


    Active Ingredient
    Terazosin HCl dihydrate 5 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    30 X 5 mg

    not in the basket chart 89473 20635

    Related information


    Dosage

    See prescribing information for full details.


    Indications

    For symptomatic treatment of urinary obstruction caused by benign prostatic hypertrophy (BPH). For mild to moderate hypertension.


    Contra-Indications

    Known hypersensitivity to terazosin HCl or any component of the product.


    Special Precautions

    See prescribing information for full details.


    Side Effects

    See prescribing information for full details.


    Drug interactions

    Caution should be observed when administered concomitantly with other antihypertensive agents, especially the calcium channel blocker verapamil, to avoid the possibility of developing significant hypotension. When using with other antihypertensive agents concomitantly, dosage reduction and retitration of either agent may be necessary.
    See prescribing information for full details.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE